Ligand validation:9F66

COH: PROTOPORPHYRIN IX CONTAINING CO

COH is a Ligand Of Interest in 9F66 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9F66_COH_A_901	85%	4%	0.097	0.962	2.19	3.52	16	29	0	1	100%	0.9469
9F5U_COH_A_901	98%	5%	0.065	0.987	1.77	3.42	12	30	1	1	100%	0.9692
9FVS_COH_A_901	97%	4%	0.067	0.985	1.91	3.6	10	28	0	1	100%	0.9584
9FW4_COH_A_901	76%	4%	0.104	0.939	1.99	3.83	15	29	1	1	100%	1
9FY4_COH_H_901	56%	4%	0.142	0.914	1.95	3.73	13	28	2	1	100%	1
2ZDP_COH_A_200	92%	24%	0.091	0.98	1.39	1.74	4	14	1	1	100%	1
2O5S_COH_X_154	91%	9%	0.087	0.975	2.35	2.19	16	16	0	1	100%	1
2O5T_COH_X_154	91%	7%	0.086	0.972	2.52	2.27	18	19	1	1	100%	1
6JVC_COH_A_512	87%	5%	0.098	0.971	1.81	3.61	13	30	0	1	100%	0.47

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.